Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
08/2000
08/10/2000DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them
08/10/2000DE19903087A1 Behandlung von erektilen Dysfunktionen mit C-Typ Natriuretischem Polypeptid (CNP) als Monotherapie oder in Kombination mit Phosphodiesterasehemmern Treatment of erectile dysfunction with C-type natriuretic polypeptide (CNP) as monotherapy or in combination with phosphodiesterase inhibitors
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361046A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000CA2360741A1 Protein with cell proliferation and cell division modulating activity and dna encoding such protein
08/09/2000EP1026245A1 Antigen protein and nucleic acid coding for said protein
08/09/2000EP1026244A1 Proteins Capable of Triggering G2/M transition and of Interacting with CDC2- and Cyclin B
08/09/2000EP1025100A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
08/09/2000EP1025096A1 Substituted chroman derivatives
08/09/2000EP1025095A1 Substituted chroman derivatives
08/09/2000EP1025094A1 Substituted indan derivatives
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1025077A1 Novel aryloxy-alkyl-dialkylamines
08/09/2000EP1024815A1 Pharmaceutical compositions for oral administration of molecular iodine
08/09/2000EP1024801A2 Method for regulating size and growth of vascularized normal tissue
08/09/2000EP1006964A4 Intrauterine chemical necrosing method, composition, and apparatus
08/09/2000CN1262681A 4,5-dihydro-[1H]-benz [g] indazole-3-carboxylic acid derivatives
08/09/2000CN1262622A Combination therapy for modulating human sexual response
08/09/2000CN1262117A Oral liquid for curing ganopathy
08/09/2000CN1262104A Chinese medicine for treating cervical erosion and its preparing process
08/09/2000CN1055237C Chinese medicine liquor for tonifying kidney and strengening Yang and producing method thereof
08/09/2000CN1055227C Medicine for treating masculine sterility and its preparing method
08/08/2000US6100378 Amplification of polypeptide joining to sex cells
08/08/2000US6100286 Methods and formulations for modulating the human sexual response
08/08/2000US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/08/2000US6100270 Bicyclic heterocyclic compounds for the treatment of impotence
08/08/2000US6099853 Vaccine containing deactivated bacteria
08/08/2000CA2177743C New alkoxy-aryl compounds, process for preparing the same and pharmaceutical compositions containing them
08/08/2000CA2018438C Imidazolyl-alkenoic acids
08/03/2000WO2000044900A2 Nucleic-acid binding proteins
08/03/2000WO2000044761A2 Ketolide antibiotics
08/03/2000WO2000044755A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
08/03/2000WO2000044753A1 Pirazino(aza)indole derivatives
08/03/2000WO2000044745A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044399A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
08/03/2000WO2000044395A1 Methods and compositions for modulating fertility
08/03/2000WO2000044388A1 Modulation of immune response by ribavirin
08/03/2000WO2000044371A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
08/03/2000CA2361271A1 Methods and compositions for modulating fertility
08/03/2000CA2361239A1 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
08/03/2000CA2360674A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2359701A1 Nucleic-acid binding proteins
08/03/2000CA2359034A1 Pyrazino(aza)indole derivatives
08/03/2000CA2358964A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000CA2357735A1 Modulation of immune response by ribavirin
08/03/2000CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/02/2000EP1023903A1 Use of life attenuated bacteria for the manufacture of a submucosal vaccine
08/02/2000EP1023277A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy
08/02/2000EP1023268A1 Isoquinolines as urokinase inhibitors
08/02/2000EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023060A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
08/02/2000CN1261798A Medicine containing yohimbine and arginine for treating erectile dysfunction
08/02/2000CN1261534A Medicinal composition containing naphthyl compound
08/02/2000CN1055000C Chinese patent medicine for curing habitual abortion
08/02/2000CN1054980C Painless induced labor liquor
08/01/2000US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
08/01/2000US6096781 2-phenyl-1-benzothiophene derivatives are useful for treatment of osteoporosis and hyperlipemia
08/01/2000US6096774 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, intiators and gas generators
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000US6096318 Antigenically modified HCG polypeptides
08/01/2000US6096317 St. John's Wort and methyl donor composition and uses thereof
08/01/2000CA2217260C Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
08/01/2000CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
08/01/2000CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
07/2000
07/27/2000WO2000043553A1 Identifying, monitoring, and treating women for breast precancer or cancer
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000043419A2 Exocytosis pathway proteins and methods of use
07/27/2000WO2000043401A1 Boron steroid mimics and pharmaceutical compositions
07/27/2000WO2000043392A2 Use of imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones as medicaments
07/27/2000WO2000043387A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
07/27/2000WO2000043378A1 New morpholinobenzamide salts
07/27/2000WO2000043038A1 Methods and devices for delivery of agents to breast milk ducts
07/27/2000WO2000043031A1 Tumor necrosis factor antagonists and their use in endometriosis
07/27/2000WO2000043029A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
07/27/2000WO2000043010A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
07/27/2000WO2000043008A1 Anti-androgens and methods for treating disease
07/27/2000WO2000042992A2 Compositions and methods for mucosal delivery
07/27/2000WO2000042841A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000CA2361272A1 33 human secreted proteins
07/27/2000CA2361123A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
07/27/2000CA2361122A1 Methods and devices for delivery of agents to breast milk ducts
07/27/2000CA2361064A1 Boron steroid mimics and pharmaceutical compositions
07/27/2000CA2360058A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
07/27/2000CA2359145A1 Exocytosis pathway proteins and methods of use
07/27/2000CA2359107A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
07/27/2000CA2359105A1 New morpholinobenzamide salts
07/27/2000CA2358971A1 Identifying, monitoring, and treating women for breast precancer or cancer
07/27/2000CA2358524A1 Compositions and methods for mucosal delivery
07/26/2000EP1022027A1 Tumor necrosis factor antagonists and their use in endometriosis
07/26/2000EP1021549A2 SENSE mRNA THERAPY
07/26/2000EP1021540A1 Human progesterone receptor complex p23-like protein